Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV PreventionABAnn Bordwine BeederBSBruce SchackmanYPYpe P. de JongNational Institute on Drug Abuse · 2010–2015 · via State University of New York Downstate Medical CenterAbstract & 3 publicationsR01DA029512-05
HCV Treatment Cost-Effectiveness in 3 IDU PopulationsBSBruce SchackmanNational Institute on Drug Abuse · 2004–2010Abstract & 20 publicationsK01DA017179-05
Researching Effective Strategies to Prevent Opioid Death (RESPOND)BSBruce SchackmanSMSean M. MurphyYBYuhua BaoMPINational Institute on Drug Abuse · 2018–2028 · via Boston Medical Center (Corporation)Abstract & 15 publicationsR01DA046527-05Active
Multi-Ethnic Drug Abuse Prevention Among New York YouthGBGil BotvinNational Institute on Drug Abuse · 1991–2007Abstract & 24 publicationsP50DA007656-11A1S1
A Collaborative System Approach to Diffusion of Evidence-Based PreventionGBGil BotvinNational Institute on Drug Abuse · 2008–2014AbstractR01DA023437-04
Probing Mechanisms of Amphetamine Action at Plasma Membrane and Vesicular Transporters in vitro and in vivoHWHarel WeinsteinNational Institute on Drug Abuse · 2017–2022 · via Columbia UniversityAbstract & 7 publicationsR01DA041510-05
A Randomized Controlled Trial of sublingual versus extended-release buprenorphine with individuals leaving Carceral Settings access, quality, and spendingSMSean M. MurphyAJAli JalaliNational Institute on Drug Abuse · 2023–2028 · via Friends Research Institute, Inc.AbstractR01DA058674-01Active
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Advanced Methods, and Knowledge TranslationBSBruce SchackmanAJAli JalaliBABrandon AdenSMSean M. Murphy+1 moreNational Institute on Drug Abuse · 2015–2030Abstract & 169 publicationsP30DA040500-12Active
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive ImpairmentDNDouglas NixonL(Lishomwa (Lish) NdhlovuHAHoward Alan FineMPINational Institute on Drug Abuse · 2020–2026Abstract & 12 publicationsR01DA052027-05Ending soon
Single cell dark matter in the context of HIV and substance useDNDouglas NixonL(Lishomwa (Lish) NdhlovuMJMichael Jay CorleyMPINational Institute on Drug Abuse · 2025–2030 · via The Feinstein Institute for Medical ResearchAbstract & 1 publicationR01DA063076-02Active
Genetically-Targeted Photo-Pharmacology for Native Opioid ReceptorsJLJoshua LevitzCLConor ListonNational Institute on Drug Abuse · 2020–2026Abstract & 5 publicationsR61DA051529-01Ending soon
Expansion of Mail-Delivered Harm Reduction Services in the U.S.CNCzarina Navos BehrendsNational Institute on Drug Abuse · 2022–2027Abstract & 2 publicationsR01DA057654-02Ending soon
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infectionL(Lishomwa (Lish) NdhlovuNational Institute on Drug Abuse · 2023–2028 · via University of MiamiAbstractR01DA058437-03Active
The Economics of Electronic Nicotine Delivery Systems: Advertising and OutcomesMFMichael F. PeskoNational Institute on Drug Abuse · 2016–2017 · via National Bureau of Economic ResearchAbstract & 5 publicationsR01DA039968-02
Agonist Specific mu-Opioid Receptor RegulationMVMichael VirkNational Institute on Drug Abuse · 2007–2011AbstractF30DA021466-03
Effects of Medication for Opioid Use Disorder on CNS immune activation and Neurocognition in People Living with HIVMJMichael Jay CorleyNational Institute on Drug Abuse · 2024–2025 · via Yale UniversityAbstractR01DA060493-01Recently ended
AMYGDALA AMPA GLUR2 DELETION AND OPIOID DEPENDENCEMJMichael J. GlassNational Institute on Drug Abuse · 2009–2011Abstract & 8 publicationsR03DA027128-02
Pathways Controlling mRNA Translation Pathways in Dopaminergic NeuronsSRSamie R JaffreyOEOlivier ElementoNational Institute on Drug Abuse · 2014–2019Abstract & 16 publicationsR01DA037755-05
Adenovirus-Based Nanoparticle VaccinesRGRonald G CrystalSMStephen M. KaminskySWStefan WorgallMPINational Institute on Drug Abuse · 2009–2014Abstract & 8 publicationsR01DA025305-03
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related InfectionsSNShashi N KapadiaYBYuhua BaoNational Institute on Drug Abuse · 2023–2027Abstract & 1 publicationR01DA057940-04Ending soon